Literature DB >> 8640859

Lack of MMTV superantigen presentation in MHC class II-deficient mice.

U Beutner1, B McLellan, E Kraus, B T Huber.   

Abstract

Mammary tumor viruses (MMTVs) as well as their endogenous counterparts encode superantigens which react with T cells expressing particular T cell receptor V beta chains. Several lines of evidence indicated that MHC class II is required for the functional presentation of these superantigens. Here we provide direct proof that the function of superantigens is abrogated in the absence of MHC class II expression. No deletion of Mls-1-reactive T cells was observed in MHC class II-deficient mice, and splenocytes from these animals did not stimulate Mls-1-reactive T cell hybrids in vitro. Furthermore, the viral spread in MHC class II-deficient mice, maternally infected with MMTV(C3H), was severely reduced. While initial infection in the gut-associated lymphocytes was comparable between MHC class II-deficient and normal mice, the level of infection in the spleen and the mammary tissue was much lower in the deficient animals. Quantitation of proviral DNA in spleen revealed a direct correlation between the magnitude of superantigen stimulation and degree of infection. These experiments document the direct effect of superantigen stimulation on viral amplification.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8640859     DOI: 10.1006/cimm.1996.0060

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  9 in total

1.  Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen.

Authors:  Chaorui Tian; Xueli Yuan; Peter T Jindra; Jessamyn Bagley; Mohamed H Sayegh; John Iacomini
Journal:  Clin Immunol       Date:  2010-05-08       Impact factor: 3.969

Review 2.  Virus-encoded superantigens.

Authors:  B T Huber; P N Hsu; N Sutkowski
Journal:  Microbiol Rev       Date:  1996-09

3.  Intercellular transfer of a soluble viral superantigen.

Authors:  M Reilly; D Mix; A A Reilly; X Y Ye; G M Winslow
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 4.  Mouse mammary tumor virus and the immune system.

Authors:  Jennifer Czarneski; John C Rassa; Susan R Ross
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

5.  A novel block to mouse mammary tumor virus infection of lymphocytes in B10.BR mice.

Authors:  Chioma M Okeoma; Ming Shen; Susan R Ross
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

6.  BALB/Mtv-null mice responding to strong mouse mammary tumor virus superantigens restrict mammary tumorigenesis.

Authors:  Sanchita Bhadra; Mary M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

7.  Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection.

Authors:  Chioma M Okeoma; Josiah Petersen; Susan R Ross
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

8.  Mtv-1 superantigen trafficks independently of major histocompatibility complex class II directly to the B-cell surface by the exocytic pathway.

Authors:  M E Grigg; C W McMahon; S Morkowski; A Y Rudensky; A M Pullen
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: role for a viral superantigen?

Authors:  R A Tripp; A M Hamilton-Easton; R D Cardin; P Nguyen; F G Behm; D L Woodland; P C Doherty; M A Blackman
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.